RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Anthrax (INACTIVE)

A collection of news and information related to Anthrax (INACTIVE) published by this site and its partners.

Top Anthrax (INACTIVE) Articles see all

Displaying items 1-5
  • 'House of Cards' recap, Season 2, Episode 4

    'House of Cards' recap, Season 2, Episode 4
    Chapter 17 opens with some verbal jousting between Frank and Remy Danton, who has been lobbying on Tusk's behalf.
  • Ex-CIA lawyer John Rizzo defends 'enhanced interrogation techniques'

    Ex-CIA lawyer John Rizzo defends 'enhanced interrogation techniques'
    When the CIA's chief lawyer, John Rizzo, first came across the term "enhanced interrogation technique" shortly after the Sept. 11 terrorist attacks, he was struck by the phrase's deceptive blandness. The words sounded mild, possibly even salutary. But...

    Emergent BioSolutions seeks to buy land from city for expansion

    Emergent BioSolutions seeks to buy land from city for expansion
    Emergent BioSolutions wants to exercise an option to buy 8 acres next to its East Baltimore manufacturing facility for an expansion that eventually could add up to 100 jobs, a company official said. The Rockville-based biotechnology company bought its...

    State weighs regulations for research labs

    State weighs regulations for research labs
    State health officials are weighing new safeguards for research laboratories and biotechnology companies that handle potentially deadly infectious pathogens, but whether they will impose any remains uncertain because they don't know how big a threat there...

    Emergent BioSolutions strikes $222M deal to buy Cangene Corp.

    Emergent BioSolutions strikes $222M deal to buy Cangene Corp.
    Rockville biotechnology company Emergent BioSolutions Inc. has struck a deal to buy Canadian firm Cangene Corp., which employs 100 people in Baltimore, for $222 million in cash, the companies said Thursday. Emergent is paying $3.24 per share for...